OpGen (OPGN) Misses Q3 EPS by 17c

OpGen (NASDAQ: OPGN) reported Q3 EPS of ($0.30), $0.17 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $448.71 million versus the consensus estimate of $1.55 million.

For earnings history and earnings-related data on OpGen (OPGN) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Amylyx ALS drug shows no serious adverse events in Phase 1 trial
• Deutsche Bank Starts Tandem Diabetes Care (TNDM) at Hold